INSIGHT: Coronavirus Vaccine Efforts Spur Contracts for Life Science, Biotech Companies

Date: March 18, 2020

Publication: Bloomberg Law

The race for a vaccine for the new coronavirus means significant opportunities for life science and biotechnology companies through government contracts. Thompson Hine’s Chip Purcell and Tom Mason discuss the government agencies seeking industry support and key issues for potential contractors. Read more.